US open: Stocks rise as bond yields hit monthly low
Fiona Cincotta June 9, 2021 11:07 PM
US stocks are set for another fairly subdued start as US treasury bond yields continue to fall even as inflationary pressures appear to be building.
Dow futures +0.02% at 34604
S&P futures +0.2% at 4236
Nasdaq futures +0.34% at 13856
FTSE -0.4% at 7073
Dax -0.45% at 15582
Euro Stoxx +0.02% at 4096
Stocks rise, tech leads as bond yields fall
US stocks are set for another fairly subdued start as US treasury bond yields continue to fall even as inflationary pressures appear to be building. Either way inflation remains the key focus for the weary market ahead of tomorrow’s US CPI data.
Yesterday’s JOLTs job openings revealed 9.3 million openings, up by 1 million highlighting an inability of firms to fill roles. With over 8 million fewer workers in the workforce than pre-pandemic companies may well need to start hiking wages into order to attract workers, pointing building inflationary pressures.
Chines CPI rose 1.3% YoY, this was up from 0.9% in April, although missed forecasts of 1.6%. PPI, however, surged to a 13 year high of 9% YoY in May, well up from 6.6% in April and ahead of forecasts. These price increases could potentially trickle out across the globe.
Yet with US treasury yields at the lowest level in a month as inflation fears are calming in the market and bets of an earlier move by the Fed easing. High growth tech stocks which are most sensitive to interest rate expectations are set for a stronger start with the Nasdaq futures set to outperform US major indices.
So called meme stocks remain very much in focus with Clover Health the latest to become the retail traders’ favorite. The stock trades 22% pre-market after 86% gains yesterday.
GameStop is due to report after hours.
Where next for the S&P?
The S&P is edging higher as it trades under 15 points from its all time high. The move higher is slowing although there is little to suggest that it won’t break through 4245 to hit fresh all time highs. It would rake a move below 4155 the confluence of the 50 sma and the ascending trendline dating bavck to November to negate the near term uptrend. A break through here could see the price drop towards 4035 the May low and the 100 sma.
Source: StoneX, TradingView
FX – USD edges higher, EUR digests mixed bag of data
The US Dollar is edging lower, tracing treasury yields southwards as expectations of a move by the Fed eases, despite signs of inflationary pressures growing.
GBP/USD is advancing after BoE Chief Economist pointed towards tapering support. Haldane saw the UK economy firing on all cylinders, with price pressures building. His bold statement to reduce support comes as he is leaving the BoE shortly. Brexit concerns are acting as a weight on the currency amid worsening relations between Britain and the EU.
GBP/USD +0.15% at 1.4176
EUR/USD +0.18% at 1.2195
Oil rises, WTI breaches $70
Oil is extending gains from the previous session amid an improving demand outlook and as concerns over Iranian oil flooding back into the market ease. WTI crude oil pushed through $70 for the first time since 2018.
Rapid vaccine rollouts in the West and the easing of lockdown restrictions, combined rising optimism of a strong driving season in the US and Europe are boosting demand expectations. The EIA upwardly revised its oil demand outlook for the US to 1.49 million barrels per day, up from 1.39 million barrels. Adding to the upbeat mood API data revealed a draw in crude oil stockpiles of 2.1 million as expected.
Separately the US Secretary of State calmed fears of Iranian oil re-entering the market by saying that even if the nuclear deal was revived with Iran hundred’s of sanction would remain in place.
EIA crude stockpile data is due later.
US crude trades +0.4% at $70.25
Brent trades +0.5% at $72.45
15:00 BoC Rate Decision
15:30 EIA Crude Oil Inventories
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.